IBDEI11J ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16916,0)
;;=R50.82^^61^777^27
;;^UTILITY(U,$J,358.3,16916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16916,1,3,0)
;;=3^Fever,Postprocedural
;;^UTILITY(U,$J,358.3,16916,1,4,0)
;;=4^R50.82
;;^UTILITY(U,$J,358.3,16916,2)
;;=^5019509
;;^UTILITY(U,$J,358.3,16917,0)
;;=R50.83^^61^777^29
;;^UTILITY(U,$J,358.3,16917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16917,1,3,0)
;;=3^Fever,Postvaccination
;;^UTILITY(U,$J,358.3,16917,1,4,0)
;;=4^R50.83
;;^UTILITY(U,$J,358.3,16917,2)
;;=^5019510
;;^UTILITY(U,$J,358.3,16918,0)
;;=R50.84^^61^777^28
;;^UTILITY(U,$J,358.3,16918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16918,1,3,0)
;;=3^Fever,Posttransfusion
;;^UTILITY(U,$J,358.3,16918,1,4,0)
;;=4^R50.84
;;^UTILITY(U,$J,358.3,16918,2)
;;=^5019511
;;^UTILITY(U,$J,358.3,16919,0)
;;=B02.23^^61^777^74
;;^UTILITY(U,$J,358.3,16919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16919,1,3,0)
;;=3^Postherpetic Polyneuropathy
;;^UTILITY(U,$J,358.3,16919,1,4,0)
;;=4^B02.23
;;^UTILITY(U,$J,358.3,16919,2)
;;=^266550
;;^UTILITY(U,$J,358.3,16920,0)
;;=B02.22^^61^777^75
;;^UTILITY(U,$J,358.3,16920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16920,1,3,0)
;;=3^Postherpetic Trigeminal Neuralgia
;;^UTILITY(U,$J,358.3,16920,1,4,0)
;;=4^B02.22
;;^UTILITY(U,$J,358.3,16920,2)
;;=^266546
;;^UTILITY(U,$J,358.3,16921,0)
;;=J03.91^^61^777^87
;;^UTILITY(U,$J,358.3,16921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16921,1,3,0)
;;=3^Tonsillitis,Acute Recurrent,Unspec
;;^UTILITY(U,$J,358.3,16921,1,4,0)
;;=4^J03.91
;;^UTILITY(U,$J,358.3,16921,2)
;;=^5008136
;;^UTILITY(U,$J,358.3,16922,0)
;;=U07.1^^61^777^16
;;^UTILITY(U,$J,358.3,16922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16922,1,3,0)
;;=3^COVID-19
;;^UTILITY(U,$J,358.3,16922,1,4,0)
;;=4^U07.1
;;^UTILITY(U,$J,358.3,16922,2)
;;=^5159070
;;^UTILITY(U,$J,358.3,16923,0)
;;=A84.81^^61^777^76
;;^UTILITY(U,$J,358.3,16923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16923,1,3,0)
;;=3^Powassan Virus Disease
;;^UTILITY(U,$J,358.3,16923,1,4,0)
;;=4^A84.81
;;^UTILITY(U,$J,358.3,16923,2)
;;=^5159071
;;^UTILITY(U,$J,358.3,16924,0)
;;=A84.89^^61^777^85
;;^UTILITY(U,$J,358.3,16924,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16924,1,3,0)
;;=3^Tick-Borne Viral Encephalitis,Other
;;^UTILITY(U,$J,358.3,16924,1,4,0)
;;=4^A84.89
;;^UTILITY(U,$J,358.3,16924,2)
;;=^5159072
;;^UTILITY(U,$J,358.3,16925,0)
;;=A84.9^^61^777^86
;;^UTILITY(U,$J,358.3,16925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16925,1,3,0)
;;=3^Tick-Borne Viral Encephalitis,Unspec
;;^UTILITY(U,$J,358.3,16925,1,4,0)
;;=4^A84.9
;;^UTILITY(U,$J,358.3,16925,2)
;;=^5000426
;;^UTILITY(U,$J,358.3,16926,0)
;;=Z11.52^^61^777^17
;;^UTILITY(U,$J,358.3,16926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16926,1,3,0)
;;=3^COVID-19 Screening
;;^UTILITY(U,$J,358.3,16926,1,4,0)
;;=4^Z11.52
;;^UTILITY(U,$J,358.3,16926,2)
;;=^5160186
;;^UTILITY(U,$J,358.3,16927,0)
;;=Z20.822^^61^777^21
;;^UTILITY(U,$J,358.3,16927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16927,1,3,0)
;;=3^Contact with & Suspected Exposure to COVID-19
;;^UTILITY(U,$J,358.3,16927,1,4,0)
;;=4^Z20.822
;;^UTILITY(U,$J,358.3,16927,2)
;;=^5160187
;;^UTILITY(U,$J,358.3,16928,0)
;;=Z86.16^^61^777^68
;;^UTILITY(U,$J,358.3,16928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16928,1,3,0)
;;=3^Personal Hx of COVID-19
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI11J 3786 printed Apr 09, 2024@20:57:26 Page 2
IBDEI11J ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16916,0)
+2 ;;=R50.82^^61^777^27
+3 ;;^UTILITY(U,$J,358.3,16916,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,16916,1,3,0)
+6 ;;=3^Fever,Postprocedural
+7 ;;^UTILITY(U,$J,358.3,16916,1,4,0)
+8 ;;=4^R50.82
+9 ;;^UTILITY(U,$J,358.3,16916,2)
+10 ;;=^5019509
+11 ;;^UTILITY(U,$J,358.3,16917,0)
+12 ;;=R50.83^^61^777^29
+13 ;;^UTILITY(U,$J,358.3,16917,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,16917,1,3,0)
+16 ;;=3^Fever,Postvaccination
+17 ;;^UTILITY(U,$J,358.3,16917,1,4,0)
+18 ;;=4^R50.83
+19 ;;^UTILITY(U,$J,358.3,16917,2)
+20 ;;=^5019510
+21 ;;^UTILITY(U,$J,358.3,16918,0)
+22 ;;=R50.84^^61^777^28
+23 ;;^UTILITY(U,$J,358.3,16918,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,16918,1,3,0)
+26 ;;=3^Fever,Posttransfusion
+27 ;;^UTILITY(U,$J,358.3,16918,1,4,0)
+28 ;;=4^R50.84
+29 ;;^UTILITY(U,$J,358.3,16918,2)
+30 ;;=^5019511
+31 ;;^UTILITY(U,$J,358.3,16919,0)
+32 ;;=B02.23^^61^777^74
+33 ;;^UTILITY(U,$J,358.3,16919,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,16919,1,3,0)
+36 ;;=3^Postherpetic Polyneuropathy
+37 ;;^UTILITY(U,$J,358.3,16919,1,4,0)
+38 ;;=4^B02.23
+39 ;;^UTILITY(U,$J,358.3,16919,2)
+40 ;;=^266550
+41 ;;^UTILITY(U,$J,358.3,16920,0)
+42 ;;=B02.22^^61^777^75
+43 ;;^UTILITY(U,$J,358.3,16920,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,16920,1,3,0)
+46 ;;=3^Postherpetic Trigeminal Neuralgia
+47 ;;^UTILITY(U,$J,358.3,16920,1,4,0)
+48 ;;=4^B02.22
+49 ;;^UTILITY(U,$J,358.3,16920,2)
+50 ;;=^266546
+51 ;;^UTILITY(U,$J,358.3,16921,0)
+52 ;;=J03.91^^61^777^87
+53 ;;^UTILITY(U,$J,358.3,16921,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,16921,1,3,0)
+56 ;;=3^Tonsillitis,Acute Recurrent,Unspec
+57 ;;^UTILITY(U,$J,358.3,16921,1,4,0)
+58 ;;=4^J03.91
+59 ;;^UTILITY(U,$J,358.3,16921,2)
+60 ;;=^5008136
+61 ;;^UTILITY(U,$J,358.3,16922,0)
+62 ;;=U07.1^^61^777^16
+63 ;;^UTILITY(U,$J,358.3,16922,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,16922,1,3,0)
+66 ;;=3^COVID-19
+67 ;;^UTILITY(U,$J,358.3,16922,1,4,0)
+68 ;;=4^U07.1
+69 ;;^UTILITY(U,$J,358.3,16922,2)
+70 ;;=^5159070
+71 ;;^UTILITY(U,$J,358.3,16923,0)
+72 ;;=A84.81^^61^777^76
+73 ;;^UTILITY(U,$J,358.3,16923,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,16923,1,3,0)
+76 ;;=3^Powassan Virus Disease
+77 ;;^UTILITY(U,$J,358.3,16923,1,4,0)
+78 ;;=4^A84.81
+79 ;;^UTILITY(U,$J,358.3,16923,2)
+80 ;;=^5159071
+81 ;;^UTILITY(U,$J,358.3,16924,0)
+82 ;;=A84.89^^61^777^85
+83 ;;^UTILITY(U,$J,358.3,16924,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,16924,1,3,0)
+86 ;;=3^Tick-Borne Viral Encephalitis,Other
+87 ;;^UTILITY(U,$J,358.3,16924,1,4,0)
+88 ;;=4^A84.89
+89 ;;^UTILITY(U,$J,358.3,16924,2)
+90 ;;=^5159072
+91 ;;^UTILITY(U,$J,358.3,16925,0)
+92 ;;=A84.9^^61^777^86
+93 ;;^UTILITY(U,$J,358.3,16925,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,16925,1,3,0)
+96 ;;=3^Tick-Borne Viral Encephalitis,Unspec
+97 ;;^UTILITY(U,$J,358.3,16925,1,4,0)
+98 ;;=4^A84.9
+99 ;;^UTILITY(U,$J,358.3,16925,2)
+100 ;;=^5000426
+101 ;;^UTILITY(U,$J,358.3,16926,0)
+102 ;;=Z11.52^^61^777^17
+103 ;;^UTILITY(U,$J,358.3,16926,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,16926,1,3,0)
+106 ;;=3^COVID-19 Screening
+107 ;;^UTILITY(U,$J,358.3,16926,1,4,0)
+108 ;;=4^Z11.52
+109 ;;^UTILITY(U,$J,358.3,16926,2)
+110 ;;=^5160186
+111 ;;^UTILITY(U,$J,358.3,16927,0)
+112 ;;=Z20.822^^61^777^21
+113 ;;^UTILITY(U,$J,358.3,16927,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,16927,1,3,0)
+116 ;;=3^Contact with & Suspected Exposure to COVID-19
+117 ;;^UTILITY(U,$J,358.3,16927,1,4,0)
+118 ;;=4^Z20.822
+119 ;;^UTILITY(U,$J,358.3,16927,2)
+120 ;;=^5160187
+121 ;;^UTILITY(U,$J,358.3,16928,0)
+122 ;;=Z86.16^^61^777^68
+123 ;;^UTILITY(U,$J,358.3,16928,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
+126 ;;=3^Personal Hx of COVID-19
